Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study — Stella

Recruiting

Back to Cocaine Use Disorder trials

Trial locations(1 site)

United States

Connecticut Mental Health Center, New Haven, Connecticut

Key details

Sponsor

Yale University

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~80 participants

Started

July 2021

Primary completion

June 2026

Age range

21 Years – 60 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov